Whitepapers
ICER finds Roche’s Hemlibra cost-effective despite high price tag
Roche’s new haemophilia treatment, Hemlibra, is has a high estimated price tag of $482,000 for the first year of treatment and $448,000 for every subsequent
February 1, 2018
